BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19436234)

  • 1. Association between the peroxisome proliferator-activated receptor gamma Pro12Ala variant and haplotype and pancreatic cancer in a high-risk cohort of smokers: a pilot study.
    Fesinmeyer MD; Stanford JL; Brentnall TA; Mandelson MT; Farin FM; Srinouanprachanh S; Afsharinejad Z; Goodman GE; Barnett MJ; Austin MA
    Pancreas; 2009 Aug; 38(6):631-7. PubMed ID: 19436234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPARG and ADIPOQ gene polymorphisms increase type 2 diabetes mellitus risk in Asian Indian Sikhs: Pro12Ala still remains as the strongest predictor.
    Sanghera DK; Demirci FY; Been L; Ortega L; Ralhan S; Wander GS; Mehra NK; Singh J; Aston CE; Mulvihill JJ; Kamboh IM
    Metabolism; 2010 Apr; 59(4):492-501. PubMed ID: 19846176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between C1431T and Pro12Ala variants of PPARγ gene and their haplotypes with susceptibility to metabolic syndrome in an Iranian population.
    Rooki H; Haerian MS; Azimzadeh P; Mirhafez R; Ebrahimi M; Ferns G; Ghayour-Mobarhan M; Zali MR
    Mol Biol Rep; 2014 May; 41(5):3127-33. PubMed ID: 24464185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Pro12Ala polymorphism in peroxisome proliferator-activated receptor-γ2 gene on metabolic syndrome risk: a meta-analysis.
    Zhang R; Wang J; Yang R; Sun J; Chen R; Luo H; Liu D; Cai D
    Gene; 2014 Feb; 535(1):79-87. PubMed ID: 24012868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analyses of association between PPAR gamma and EPHX1 polymorphisms and susceptibility to COPD in a Hungarian cohort, a case-control study.
    Penyige A; Poliska S; Csanky E; Scholtz B; Dezso B; Schmelczer I; Kilty I; Takacs L; Nagy L
    BMC Med Genet; 2010 Nov; 11():152. PubMed ID: 21044285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor gamma/Pro12Ala polymorphism and peroxisome proliferator-activated receptor gamma coactivator-1 alpha/Gly482Ser polymorphism in patients with sarcoidosis.
    Maver A; Medica I; Salobir B; Tercelj-Zorman M; Sabovic M; Petrovic D; Peterlin B
    Sarcoidosis Vasc Diffuse Lung Dis; 2008 Sep; 25(1):29-35. PubMed ID: 19070258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common genetic variants in peroxisome proliferator-activated receptor-γ (PPARG) and type 2 diabetes risk among Women's Health Initiative postmenopausal women.
    Chan KH; Niu T; Ma Y; You NC; Song Y; Sobel EM; Hsu YH; Balasubramanian R; Qiao Y; Tinker L; Liu S
    J Clin Endocrinol Metab; 2013 Mar; 98(3):E600-4. PubMed ID: 23386649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pro12Ala polymorphism of the peroxisome proliferatoractivated receptor-gamma gene is associated with metabolic syndrome and surrogate measures of insulin resistance in healthy men: interaction with smoking status.
    Tellechea ML; Aranguren F; Pérez MS; Cerrone GE; Frechtel GD; Taverna MJ
    Circ J; 2009 Nov; 73(11):2118-24. PubMed ID: 19745552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the PPAR-gamma2 Pro12Ala polymorphism and ACE inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: evidence from BENEDICT.
    De Cosmo S; Motterlini N; Prudente S; Pellegrini F; Trevisan R; Bossi A; Remuzzi G; Trischitta V; Ruggenenti P;
    Diabetes; 2009 Dec; 58(12):2920-9. PubMed ID: 19720797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Pro12Ala polymorphism of the PPAR-gamma2 gene affects associations of fish intake and marine n-3 fatty acids with glucose metabolism.
    Ylönen SK; Salminen I; Lyssenko V; Virtanen SM; Groop L; Aro A; Saloranta C;
    Eur J Clin Nutr; 2008 Dec; 62(12):1432-9. PubMed ID: 17700648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in first-degree relatives of subjects with polycystic ovary syndrome.
    Yilmaz M; Ergün MA; Karakoç A; Yurtçu E; Yetkin I; Ayvaz G; Cakir N; Arslan M
    Gynecol Endocrinol; 2005 Oct; 21(4):206-10. PubMed ID: 16316841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPARgamma Pro12Ala polymorphism and risk of acute coronary syndrome in a prospective study of Danes.
    Vogel U; Segel S; Dethlefsen C; Tjønneland A; Saber AT; Wallin H; Jensen MK; Schmidt EB; Andersen PS; Overvad K
    BMC Med Genet; 2009 Jun; 10():52. PubMed ID: 19500413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of the Pro12Ala and C1431T variants of PPARG and their haplotypes with susceptibility to Type 2 diabetes.
    Doney ASF; Fischer B; Cecil JE; Boylan K; McGuigan FE; Ralston SH; Morris AD; Palmer CNA
    Diabetologia; 2004 Mar; 47(3):555-558. PubMed ID: 14730381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ala12 variant of the peroxisome proliferator-activated receptor-gamma gene (PPARG) is associated with higher polyunsaturated fat in adipose tissue and attenuates the protective effect of polyunsaturated fat intake on the risk of myocardial infarction.
    Ruiz-Narváez EA; Kraft P; Campos H
    Am J Clin Nutr; 2007 Oct; 86(4):1238-42. PubMed ID: 17921408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor-gamma Pro12Ala polymorphism could be a risk factor for gastric cancer.
    Zhao J; Zhi Z; Song G; Wang J; Wang C; Ma H; Yu X; Sui A; Zhang H
    Asian Pac J Cancer Prev; 2015; 16(6):2333-40. PubMed ID: 25824760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome Proliferator-Activated Receptor Gamma Pro12Ala/C161T Genotypes and Risky Haplotype Altering Risk of Breast Cancer: A Turkish Case-Control Study.
    Unal E; Aslan EI; Ozturk T; Kurnaz Gomleksiz O; Kucukhuseyin O; Tuzuner MB; Seyhan MF; Ozturk O; Yilmaz Aydogan H
    Biochem Genet; 2021 Dec; 59(6):1413-1426. PubMed ID: 33893920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of the peroxisome proliferator-activated receptor-gamma2 Pro12Ala but not the C1431T gene variants with lower body mass index in Type 2 diabetes.
    Mohamed MB; Mtiraoui N; Ezzidi I; Chaieb M; Mahjoub T; Almawi WY
    J Endocrinol Invest; 2007 Dec; 30(11):937-43. PubMed ID: 18250615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of the C161T but not Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma on colorectal cancer in an Indian population.
    Jiang J; Gajalakshmi V; Wang J; Kuriki K; Suzuki S; Nakamura S; Akasaka S; Ishikawa H; Tokudome S
    Cancer Sci; 2005 Aug; 96(8):507-12. PubMed ID: 16108832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma with polycystic ovary syndrome: a meta-analysis.
    Tang ST; Wang CJ; Tang HQ; Peng WJ; Wang YM; Zhang Q
    Mol Biol Rep; 2012 Oct; 39(10):9649-60. PubMed ID: 22729915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPARG gene Pro12Ala variant contributes to the development of non-alcoholic fatty liver in middle-aged and older Chinese population.
    Yang Z; Wen J; Li Q; Tao X; Ye Z; He M; Zhang W; Huang Y; Chen L; Ling C; Qu S; Hu R
    Mol Cell Endocrinol; 2012 Jan; 348(1):255-9. PubMed ID: 21939732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.